Publications by authors named "H T Baberg"
Article Synopsis
- A nationwide study analyzed the impact of oral anticoagulants (OACs) on mortality and readmission rates in patients with heart failure (HF) and atrial fibrillation (AF) between 2017-2019.
- The study included over 180,000 cases and found that 80.6% of patients were prescribed OACs, with a mortality rate of 19.1% and a readmission rate of 29.9%.
- The results indicated that OACs significantly reduced the risk of death and readmissions, but there were no significant differences in outcomes between types of OACs like vitamin K antagonists (VKAs) and newer options like direct factor Xa inhibitors (FXaIs
Objectives: We aimed to define and assess risk-specific adverse outcomes after transcatheter aortic valve implantation (TAVI) in an all-comers patient population based on German administrative claims data.
Methods: Administrative claims data of patients undergoing transvascular TAVI between 2017 and 2019 derived from the largest provider of statutory health-care insurance in Germany were used. Patients' risk profile was assessed using the established Hospital Frailty Risk (HFR) score and 30-day adverse events were evaluated.
Objectives: To describe the use of drug-eluting stents (DESs) in the largest population of statutory health insurance members in Germany, including newly developed bio-resorbable vascular scaffolds (BVSs), and to evaluate 1-year complication rates of DES as compared with bare metal stents (BMSs) in this cohort.
Design: Routine data analysis of statutory health insurance claims data from the years 2008 to 2014.
Setting: The German healthcare insurance Allgemeine Ortskrankenkasse covers approximately 30% of the German population and is the largest nationwide provider of statutory healthcare insurance in Germany.
Objectives: We aimed to analyse the short-term and long-term outcome of patients with end-stage renal disease (ESRD) undergoing percutaneous intervention (PCI) as compared to coronary artery bypass surgery (CABG) to evaluate the optimal coronary revascularisation strategy.
Design: Retrospective analysis of routine statutory health insurance data between 2010 and 2012.
Main Outcome Measures: Primary outcome was adjusted all-cause mortality after 30 days and major adverse cardiovascular and cerebrovascular events at 1 year.
Background: Data on 1-year complication and follow-up intervention rates after coronary angiography (CA) and percutaneous coronary intervention (PCI) in German clinical routine are sparse. This analysis aims to determine these rates.
Methods: The analysis uses 2009 AOK claims data.